Trend-Following Backtester · Guide · backtest 한국어

etf · DE

Xtrackers MSCI World Health Care UCITS ETF backtest

10 trend-following strategies were compared on the full daily history of Xtrackers MSCI World Health Care UCITS ETF. 0 beat buy-and-hold CAGR; ROC 모멘텀 ranks first by Sharpe, matching the main backtester.

Data 2016-04-18 ~ 2026-07-31daily bars 2,613 (10.3 years)Costs 0.5%Venue XETRMonthly snapshot 2026-07-31

Results by strategy

0 of 10 beat buy and hold (CAGR 8.2%, drawdown -26.1%).

Sharpe leader (same as main): ROC 모멘텀 — CAGR 8.1%, MDD -26.5%, Sharpe 0.63, 90% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ROC 모멘텀
n=142, threshold=-0.09
8.1%-26.5%0.630.312.2x790%
SMA 크로스오버
fast=59, slow=190
5.1%-26.1%0.460.201.7x1571%
Donchian 채널 돌파
entryN=19, exitN=82
4.3%-18.0%0.400.241.5x2385%
EMA 크로스오버
fast=55, slow=182
3.8%-26.1%0.350.151.5x1577%
볼린저 밴드 돌파
n=50, k=2.9
1.0%-6.3%0.290.171.1x99%
Supertrend
period=20, mult=4.5
2.1%-20.8%0.250.101.2x4765%
Keltner 채널 돌파
emaPeriod=39, atrPeriod=14, mult=3.8
1.0%-9.4%0.220.101.1x2118%
MACD
fast=30, slow=33, signal=27
0.6%-20.0%0.110.031.1x8950%
ADX / DI 방향성
period=24, threshold=33
0.0%-1.7%0.020.011.0x21%
Parabolic SAR
step=0.005, maxStep=0.26
-3.4%-33.3%-0.30-0.100.7x10358%
Buy and hold8.2%-26.1%0.600.312.2x1100%
1x 2017 2019 2021 2023 2025 ROC 모멘텀Buy and hold
ROC 모멘텀: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -7% -13% -20% -26% 2017 2019 2021 2023 2025 Buy and holdROC 모멘텀
ROC 모멘텀 maximum drawdown -26.5% (2020-02-19 → 2020-03-24), recovered after 478 days.

Rules of the top strategy

Rides the trend when recent return (momentum) over a window is above a threshold.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next